Company / Working Capital per Share
Avalo Therapeutics, Inc. Working Capital per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$8.82
FY2025
5-year range
-$0.61 / $164.55
FY2021-FY2025
Trend
-94.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has fluctuated over the past 9 years, ranging from $-0.61 in FY2022 to $164.55 in FY2024.
Based on SEC 10-K filings.
8.82 in FY2025 with a 5-year CAGR of +105.1%.
Declined from $96.12 to $8.82 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +105.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, working capital per share decreased 94.6% year-over-year.
- Peak working capital per share was recorded in FY2024.
- Lowest working capital per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.82 | -94.6% |
| FY2024 | $164.55 | +71.2% |
| FY2023 | $96.12 | +15956.4% |
| FY2022 | -$0.61 | -208.4% |
| FY2021 | $0.56 | +130.3% |
| FY2020 | $0.24 | +78.1% |
| FY2019 | $0.14 | +199.5% |
| FY2018 | -$0.14 | -211.5% |
| FY2017 | -$0.04 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026